Aptamers as an approach to targeted cancer therapy
Abstract Conventional cancer treatments can cause serious side effects because they are not specific to cancer cells and can damage healthy cells. Aptamers often are single-stranded oligonucleotides arranged in a unique architecture, allowing them to bind specifically to target sites. This feature m...
Main Authors: | Fatemeh Mahmoudian, Azin Ahmari, Shiva Shabani, Bahman Sadeghi, Shohreh Fahimirad, Fahimeh Fattahi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-03-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12935-024-03295-4 |
Similar Items
-
Aptamers and antibodies: rivals or allies in cancer targeted therapy?
by: Lisa Agnello, et al.
Published: (2021-02-01) -
Aptamers, the Nucleic Acid Antibodies, in Cancer Therapy
by: Zhaoying Fu, et al.
Published: (2020-04-01) -
Aptamer selection and applications for breast cancer diagnostics and therapy
by: Mei Liu, et al.
Published: (2017-11-01) -
Advances in Oligonucleotide Aptamers for NSCLC Targeting
by: Deborah Rotoli, et al.
Published: (2020-08-01) -
Cell-type-specific, Aptamer-functionalized Agents for Targeted Disease Therapy
by: Jiehua Zhou, et al.
Published: (2014-01-01)